Skip to content

Clinical trials

Phase 1 Lung Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20101
20121
20134
20151
20161
20194
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting2
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Edinburgh2
Anaveon AG1
Blueprint Medicines Corporation1
Cancer Research UK1
Clovis Oncology, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Imperial College London1
Institute of Cancer Research, United Kingdom1
MedImmune LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms21
Carcinoma, Non-Small-Cell Lung11
Breast Neoplasms4
Neoplasms4
Ovarian Neoplasms4
Urinary Bladder Neoplasms4
Head and Neck Neoplasms3
Kidney Neoplasms3
Colonic Neoplasms2
Colorectal Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.